Skip to content

WatchPAT Compared to PSG at 8500'

Assessment of Sleep-related Respiratory Disorders at High Altitude With the WatchPAT200TMU Compared to PSG.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04249011
Enrollment
22
Registered
2020-01-30
Start date
2018-05-02
Completion date
2019-12-10
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorder; Breathing-Related

Brief summary

Subjects who consent to participate in the research will undergo a simultaneous recording of inlab PSG and WatchPAT200 for comparing the WatchPAT data to PSG at an altitude of 8500'.

Detailed description

The efficacy of the WP200U will be evaluated by comparing it to the PSG manual scoring of sleep disordered breathing (SDB) parameter using the PSG manual scoring as a gold standard

Interventions

None listed

Sponsors

Itamar-Medical, Israel
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and females ≥ age 17yrs * Subject is able to read understand and sign the informed consent form. * Willing to sleep with the WP200U and PSG simultaneously in the sleep lab.

Exclusion criteria

* Use of one of the following medications: alpha blockers, short acting nitrates (less than 3 hours before the study). * Any condition that in the opinion of the investigator may adversely affect the safety of the patient or would limit the patient ability to complete the study.

Design outcomes

Primary

MeasureTime frame
Comparison of AHI and ODI as scored automatically by the WatchPAT compared to manual scoring of full night PSG.8 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026